| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 748 |
| 1 | ADALIMUMAB | 703 |
| 2 | METHOTREXATE SODIUM | 579 |
| 3 | METHOTREXATE | 531 |
| 4 | INFLIXIMAB | 451 |
| 5 | RITUXIMAB | 380 |
| 6 | AZATHIOPRINE | 257 |
| 7 | TOCILIZUMAB | 251 |
| 8 | LEFLUNOMIDE | 231 |
| 9 | PREDNISONE | 230 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE VALERATE | 29 | 0.0462 |
| 1 | GOLD | 105 | 0.0181 |
| 2 | TETRAHYDROZOLINE HYDROCHLORIDE | 3 | 0.0102 |
| 3 | ASPRIN AND CAFFEINE | 1 | 0.0082 |
| 4 | FOSFOMYCIN TROMETHAMINE | 5 | 0.0082 |
| 5 | PENICILLIN G | 19 | 0.0081 |
| 6 | NELARABINE | 6 | 0.0062 |
| 7 | FINGOLIMOD HYDROCHLORIDE | 27 | 0.0053 |
| 8 | CASTOR OIL | 1 | 0.0052 |
| 9 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI | 1 | 0.0049 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1171 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 625 |
| 2 | Corticosteroid [EPC] | 572 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 533 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 466 |
| 5 | Proton Pump Inhibitor [EPC] | 261 |
| 6 | Purine Antimetabolite [EPC] | 259 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 253 |
| 8 | Vitamin C [EPC] | 244 |
| 9 | Antirheumatic Agent [EPC] | 231 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Purine Antimetabolite [EPC] | 259 | 0.0026 |
| 1 | Enzyme Stabilizer [EPC] | 3 | 0.0026 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 39 | 0.0023 |
| 3 | Antirheumatic Agent [EPC] | 231 | 0.0022 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 29 | 0.0021 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 625 | 0.0020 |
| 6 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 253 | 0.0018 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 227 | 0.0016 |
| 9 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |